← Browse by Condition
Medical Condition
malignancy
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3, Phase 1, Phase 2
NCT05770544 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT06988475 Phase 2, Phase 3
Recruiting
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
Enrollment
30 pts
Location
United Kingdom
Sponsor
Cancer Research UK
NCT05749302 Phase 2, Phase 3
Recruiting
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Enrollment
500 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
NCT06789601 Phase 1, Phase 2
Recruiting
Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository
Enrollment
100 pts
Location
United States
Sponsor
Brigham and Women's Hospital